1. Drenichev, M. S. Cytokinin nucleosides – natural compounds with a unique spectrum biological activities / M.S. Drenichev, V.E. Oslovsky, S.N. Mikhailov // Curr. Top. Med. Chem. – 2016. – Vol. 16, №23. – P. 2562-2576. https://doi. org/10.2174/1568026616666160414123717

2. Rosemeyer, H. The chemodiversity of purine as a constituent of natural products / H. Rosemeyer // Chem. Biodivers. – 2004. – Vol. 1, №3. – P. 361–401. https://doi.org/10.1002/cbdv.200490033

3. Романов, Г.А. Как цитокинины действуют на клетку / Г.А. Романов // Физиология растений. – 2009. – Т. 56, №2. – С. 295–319.

4. Preparation, biological activity and endogenous occurrence of N6-benzyladenosines / K. Doležal [et al.] // Bioorg. Med. Chem. – 2007. – Vol. 15, №11. – P. 3737–3747. https://doi.org/10.1016/j.bmc.2007.03.038

5. The discovery and synthesis of highly potent, A2a receptor agonists / S.E. Keeling [et al.] // Bioorg. Med. Chem. Lett. – 2000. – Vol. 10, №4. – P. 403–406. https://doi.org/10.1016/s0960-894x(00)00017-2

6. N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists / Е. Elzein [et al.] // Bioorg. Med. Chem. Lett. – 2007. – Vol. 17, №1. – Р. 161–166. https://doi.org/10.1016/j.bmcl.2006.09.065

7. 5-C-Ethyltetrazolyl-N6-substituted adenosine and 2-chloroadenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists / R. Petrelli [et al.] // J. Med. Chem. – 2015. – Vol. 58, №5. – P. 2560–2566. https://doi.org/10.1021/acs.jmedchem.5b00074

8. Chemical modification of the plant isoprenoid cytokinin N6-isopentenyladenosine yields a selective inhibitor of human enterovirus EV 71 replication / V.I. Tararov [et al.] // Eur. J. Med. Chem. – 2015. – Vol. 90. – P. 406–413. https://doi. org/10.1016/j.ejmech.2014.11.048

9. Anticancer activity of natural cytokinins: a structure-activity relationship study / J. Voller [et al.] // Phytochemistry. – 2010. – Vol. 71, №11–12. – P. 1350–1359. https://doi.org/10.1016/j.phytochem.2010.04.018

10. Anti-malarial activity of N6-modified purine analogues / K. Too [et al.] // Bioorg. Med. Chem. – 2007. – Vol. 15, №16. – P. 5551–5562. https://doi.org/10.1016/j.bmc.2007.05.038

11. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents / Y.A. Kim [et al.] // Biochem. Pharmacol. – 2007. – Vol. 73, №10. – P. 1558–1572. https://doi. org/10.1016/j.bcp.2007.01.026

12. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N6-substituted adenosine / J.C. Bressi [et al.] // J. Med. Chem. – 2000. – Vol. 43, №22. – P. 4135–4150. https://doi.org/10.1021/jm000287a

13. Fleysher, M.H. N6-Substituted adenosines: synthesis, biological activity, and some structure-activity relationships / M.H. Fleysher // J. Med. Chem. – 1972. – Vol. 15, №2. – P. 187–191. https://doi.org/10.1021/jm00272a015

14. 6-N-Alkyladenosines: synthesis and evaluation of in vitro anticancer activity / R. Ottria [et al.] // Bioorg. Med. Chem. – 2010. – Vol. 18, №23. – P. 8396–8402. https://doi.org/10.1016/j.bmc.2010.09.030

15. Synthesis of novel 6-(4-substituted piperazine-1-yl)-9-(β-D-ribofuranosyl) purine derivatives, which lead to senescence-induced cell death in liver cancer cells / M. Tuncbilek [et al.] // J. Med. Chem. – 2012. – Vol. 55, №7. – P. 3058–3065. https://doi.org/10.1021/jm3001532

16. Bredereck, H. Über methylierte Nucleoside und Purine und ihre pharmakologischen Wirkungen, I. Mitteil.: Methylierung von Nucleosiden durch Diazomethan / H. Bredereck, A. Martini // Chem. Ber. – 1947. – Vol. 80, №5. – P. 401– 405. https://doi.org/10.1002/cber.19470800505

17. Ikehara, M. Studies of nucleosides and nucleotides. XXVI. Further studies on the chlorination of inosine derivatives with dimethylformamide – thionyl chloride complex / M. Ikehara, H. Uno // Chem. Pharm. Bull. – 1965. – Vol. 13, №2. – P. 221–223. https://doi.org/10.1248/cpb.13.221

18. Robins, M. J. Nucleic acid related compounds. 33. Conversions of adenosine and guanosine to 2,6-dichloro, 2-amino6-chloro, and derived purine nucleosides / M.J. Robins, B. Uznanski // Can. J. Chem. – 1981. – Vol. 59, №. 17. – P. 2601–2607. https://doi.org/10.1139/v81-374

19. Alternative and improved synthesis of highly potent and selective A3 adenosine receptor agonists, Cl-IB-MECA and Thio-Cl-IB-MECA / X. Hou [et al.] // Arch. Pharm. Res. – 2007. – Vol. 30, №10. – P. 1205–1209. https://doi.org/10.1007/ bf02980260

20. Dekker, C.A. Separation of nucleoside mixtures on Dowex-1 (OH– ) / C.A. Dekker // J. Amer. Chem. Soc. – 1965. – Vol. 87, №17. – P. 4027–4029. https://doi.org/10.1021/ja01095a073

21. Schaffer, H. J. Synthesis of potential anticancer agents. XIV. Ribosides of 2,6-disubstituted purines / H.J. Schaffer, H.J. Thomas // J. Amer. Chem. Soc. – 1958. – Vol. 80, №14. – P. 3738–3742. https://doi.org/10.1021/ja01547a068

22. Fiorini, M.T. Solution-phase synthesis of 2,6,9-trisubstituted purines / M.T. Fiorini, C. Abell // Tetrahedron Lett. – 1998. – Vol. 39, №13. – P. 1827–1830. https://doi.org/10.1016/s0040-4039(98)00098-7

23. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor / M.P. Bosch [et al.] // J. Med. Chem. – 2004. – Vol. 47, №. 16. – P. 4041–4053. https://doi.org/10.1021/jm031143+

24. Mason, S.F. Purine studies. Part II. The ultra-violet absorption spectra of some mono- and poly-substituted purines / S.F. Mason // J. Chem. Soc. – 1954. – P. 2071–2081. https://doi.org/10.1039/jr9540002071

25. Synthesis of sugar-modified 2,6-diaminopurine and guanine nucleosides from guanosine via transformation of 2-aminoadenosine and enzymatic deamination with adenosine deaminase / M.J. Robins [et al.] // Can. J. Chem. – 1997. – Vol. 75, №6. – P. 762–767. https://doi.org/10.1139/v97-092